日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Brucella abortus Elongation factor Tu (tuf1) CSB-YP649805BMN
CSB-EP649805BMN
CSB-BP649805BMN
CSB-MP649805BMN
CSB-EP649805BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus UPF0260 protein BAB1_1496 (BAB1_1496) CSB-YP649806BMN
CSB-EP649806BMN
CSB-BP649806BMN
CSB-MP649806BMN
CSB-EP649806BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus GTPase Der (der) CSB-YP649807BMN
CSB-EP649807BMN
CSB-BP649807BMN
CSB-MP649807BMN
CSB-EP649807BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus 1-deoxy-D-xylulose-5-phosphate synthase (dxs), partial CSB-YP649808BMN
CSB-EP649808BMN
CSB-BP649808BMN
CSB-MP649808BMN
CSB-EP649808BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Phosphatidylserine decarboxylase proenzyme (psd) CSB-YP649809BMN
CSB-EP649809BMN
CSB-BP649809BMN
CSB-MP649809BMN
CSB-EP649809BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Cytochrome c-type biogenesis protein CcmE (ccmE), partial CSB-YP649810BMN
CSB-EP649810BMN
CSB-BP649810BMN
CSB-MP649810BMN
CSB-EP649810BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus GTP pyrophosphokinase rsh (rsh), partial CSB-YP649811BMN
CSB-EP649811BMN
CSB-BP649811BMN
CSB-MP649811BMN
CSB-EP649811BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Aspartate--tRNA ligase (aspS), partial CSB-YP649812BMN
CSB-EP649812BMN
CSB-BP649812BMN
CSB-MP649812BMN
CSB-EP649812BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus 50S ribosomal protein L13 (rplM) CSB-YP649813BMN
CSB-EP649813BMN
CSB-BP649813BMN
CSB-MP649813BMN
CSB-EP649813BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP649814BMN
CSB-EP649814BMN
CSB-BP649814BMN
CSB-MP649814BMN
CSB-EP649814BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase (cobT) CSB-YP649815BMN
CSB-EP649815BMN
CSB-BP649815BMN
CSB-MP649815BMN
CSB-EP649815BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Serine--tRNA ligase (serS) CSB-YP649816BMN
CSB-EP649816BMN
CSB-BP649816BMN
CSB-MP649816BMN
CSB-EP649816BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Cytochrome c biogenesis ATP-binding export protein CcmA (ccmA) CSB-YP649817BMN
CSB-EP649817BMN
CSB-BP649817BMN
CSB-MP649817BMN
CSB-EP649817BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Integration host factor subunit beta (ihfB) CSB-YP649818BMN
CSB-EP649818BMN
CSB-BP649818BMN
CSB-MP649818BMN
CSB-EP649818BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP649819BMN
CSB-EP649819BMN
CSB-BP649819BMN
CSB-MP649819BMN
CSB-EP649819BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Urease accessory protein UreF 1 (ureF1) CSB-YP649820BMN
CSB-EP649820BMN
CSB-BP649820BMN
CSB-MP649820BMN
CSB-EP649820BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus 3-methyl-2-oxobutanoate hydroxymethyltransferase (panB) CSB-YP649821BMN
CSB-EP649821BMN
CSB-BP649821BMN
CSB-MP649821BMN
CSB-EP649821BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Recombination protein RecR (recR) CSB-YP649822BMN
CSB-EP649822BMN
CSB-BP649822BMN
CSB-MP649822BMN
CSB-EP649822BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Enolase (eno) CSB-YP649823BMN
CSB-EP649823BMN
CSB-BP649823BMN
CSB-MP649823BMN
CSB-EP649823BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Brucella abortus Phosphoribosyl-AMP cyclohydrolase (hisI) CSB-YP649824BMN
CSB-EP649824BMN
CSB-BP649824BMN
CSB-MP649824BMN
CSB-EP649824BMN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×